Tolerability and efficacy of the trifunctional antibody removab<sup>® </sup>(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

Tolerability and efficacy of the trifunctional antibody removab<sup>® </sup>(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

Bibliographic Details
Main Authors:	Bois A du, Moiseenko V, Biakhov M, Eiermann W, Ströhlein M, Makhson A, Lichinitser M, Pfisterer J, Schmalfeldt B, Sommer H, Gorbounova V, Burges A, Wimberger P, Kimmig R
Format:	Article
Language:	English
Published:	BMC 2004-07-01
Series:	Cancer Cell International

Similar Items

Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab®)
by: Diane Seimetz
Published: (2011-01-01)

Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis
by: Lindhofer Horst, et al.
Published: (2009-02-01)

A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM<sup>−</sup>/CD133<sup>−</sup> nonStem Cells into EpCAM<sup>+</sup>/CD133<sup>+</sup> Liver Cancer Stem Cells in HCC Cell Line HuH7
by: Zeynep Firtina Karagonlar, et al.
Published: (2020-05-01)

ALCAM: A Novel Surface Marker on EpCAM<sup>low</sup> Circulating Tumor Cells
by: Rossana Signorelli, et al.
Published: (2022-08-01)

The Detection of Immunity against WT1 and SMAD4<sup>P130L</sup> of EpCAM<sup>+</sup> Cancer Cells in Malignant Pleural Effusion
by: Terutsugu Koya, et al.
Published: (2022-10-01)

Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM<sup>+</sup> and CD90<sup>+</sup> Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model
by: Mohamed Moustafa, et al.
Published: (2022-04-01)

SNAI2 Attenuated the Stem-like Phenotype by Reducing the Expansion of EPCAM<sup>high</sup> Cells in Cervical Cancer Cells
by: Xian Liu, et al.
Published: (2023-01-01)

Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
by: Stefan Schönberger, et al.
Published: (2020-05-01)

Enhancing Prediction Performance by Add-On Combining Circulating Tumor Cell Count, CD45<sup>neg</sup> EpCAM<sup>neg</sup> Cell Count on Colorectal Cancer, Advance, and Metastasis
by: Sherry Yueh-Hsia Chiu, et al.
Published: (2021-05-01)

Anti-inflammatory and Anti-oxidant Activity of Hidrox<sup>®</sup> in Rotenone-Induced Parkinson’s Disease in Mice
by: Rosalba Siracusa, et al.
Published: (2020-09-01)

Complexes of Ni<sup>II</sup>, Co<sup>II</sup>, Zn<sup>II</sup>, and Cu<sup>II</sup> with Promising Anti-Tuberculosis Drug: Solid-State Structures and DFT Calculations
by: Mohamed Ali Ahmed, et al.
Published: (2023-04-01)

In Vivo Anti-Inflammatory Potential of Viscozyme<sup>®</sup>-Treated Jujube Fruit
by: Yoonsu Kim, et al.
Published: (2020-08-01)

Identification of a novel anti-σ<sup>E </sup>factor in <it>Neisseria meningitidis</it>
by: Pannekoek Yvonne, et al.
Published: (2010-06-01)

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018-08-01)

Ca<sup>2+</sup>/Sr<sup>2+</sup> Selectivity in Calcium-Sensing Receptor (CaSR): Implications for Strontium’s Anti-Osteoporosis Effect
by: Diana Cheshmedzhieva, et al.
Published: (2021-10-01)

Enhanced Upconversion Photoluminescence of LiYF<sub>4</sub>: Yb<sup>3+</sup>/Ho<sup>3+</sup> Crystals by Introducing Mg<sup>2+</sup> Ions for Anti-Counterfeiting Recognition
by: Dongdong Li, et al.
Published: (2022-08-01)

Identification of NLRP3<sup>PYD</sup> Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity
by: Soroush Moasses Ghafary, et al.
Published: (2022-01-01)

Atripla<sup>R</sup>/anti-TB combination in TB/HIV patients. Drug in focus
by: Semvua Hadija H, et al.
Published: (2011-11-01)

CD19<sup>+</sup> CD24<sup>hi</sup> CD38<sup>hi</sup> Regulatory B Cells and Memory B Cells in Periodontitis: Association with Pro-Inflammatory and Anti-Inflammatory Cytokines
by: Helal F. Hetta, et al.
Published: (2020-06-01)

Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
by: Antonio Hrvat, et al.
Published: (2024-04-01)

Effect of Structural Changes Induced by Deletion of <sup>54</sup>FLRAPSWF<sup>61</sup> Sequence in αB-crystallin on Chaperone Function and Anti-Apoptotic Activity
by: Sundararajan Mahalingam, et al.
Published: (2021-10-01)

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by: Guanjie Li, et al.
Published: (2022-06-01)

Characterization of human anti-EpCAM antibodies for developing an antibody–drug conjugate
by: Hiroyuki Satofuka, et al.
Published: (2023-03-01)

Design, Synthesis, and Characterization of a Novel Blue-Green Long Afterglow BaYAl<sub>3</sub>O<sub>7</sub>:Eu<sup>2</sup><sup>+</sup>, Nd<sup>3</sup><sup>+</sup> Phosphor and Its Anti-Counterfeiting Application
by: Jiao Wu, et al.
Published: (2023-08-01)

Recognition of Dimeric Lewis X by Anti-Dimeric Le<sup>x</sup> Antibody SH2
by: Sinthuja Jegatheeswaran, et al.
Published: (2020-09-01)

The Anti-ADAMTS-5 Nanobody<sup>®</sup> M6495 Protects Cartilage Degradation Ex Vivo
by: Anne Sofie Siebuhr, et al.
Published: (2020-08-01)

Harnessing the IL-21-BATF Pathway in the CD8<sup>+</sup> T Cell Anti-Tumor Response
by: Paytsar Topchyan, et al.
Published: (2021-03-01)

Characterization of <sup>β</sup><i>N</i>-Octadecanoyl-5-hydroxytryptamide Anti-Inflammatory Effect
by: Thais Biondino Sardella Giorno, et al.
Published: (2021-06-01)

An NAD<sup>+</sup> dependent/sensitive transcription system: Toward a novel anti-cancer therapy
by: Fumiaki Uchiumi, et al.
Published: (2020-05-01)

Structure and Photoluminescence Properties of Rare-Earth (Dy<sup>3+</sup>, Tb<sup>3+</sup>, Sm<sup>3+</sup>)-Doped BaWO<sub>4</sub> Phosphors Synthesized via Co-Precipitation for Anti-Counterfeiting
by: Jae-yong Jung, et al.
Published: (2020-09-01)

Enhanced Fluorescence Characteristics of SrAl<sub>2</sub>O<sub>4</sub>: Eu<sup>2+</sup>, Dy<sup>3+</sup> Phosphor by Co-Doping Gd<sup>3+</sup> and Anti-Counterfeiting Application
by: Peng Gao, et al.
Published: (2023-07-01)

Ginseng<sup>®</sup> Alleviates Malathion-Induced Hepatorenal Injury through Modulation of the Biochemical, Antioxidant, Anti-Apoptotic, and Anti-Inflammatory Markers in Male Rats
by: Heba I. Ghamry, et al.
Published: (2022-05-01)

Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4<sup>+</sup> BTLA<sup>+</sup> T Cells in Tumor Microenvironment of Mycosis Fungoides
by: Tony T. Jiang, et al.
Published: (2021-11-01)

A Potential Biomarker of Dynamic Change in Peripheral CD45RA<sup>−</sup>CD27<sup>+</sup>CD127<sup>+</sup> Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma
by: Mei Sakuma, et al.
Published: (2023-07-01)

Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
by: Pflanz Stefan, et al.
Published: (2010-11-01)

The Potential of T Cell Factor 1 in Sustaining CD8<sup>+</sup> T Lymphocyte-Directed Anti-Tumor Immunity
by: Sungmin Jung, et al.
Published: (2021-01-01)

Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K<sup>+</sup> Channels in T-Lymphocytes
by: Hong T. L. Phan, et al.
Published: (2021-10-01)

GanedenBC<sup>30™ </sup>cell wall and metabolites: anti-inflammatory and immune modulating effects <it>in vitro</it>
by: Carter Steve G, et al.
Published: (2010-03-01)

Heterogeneity of EpCAM-positive cells in low-grade serous ovarian carcinoma ascitic fluid: a clinical case
by: E. V. Kaigorodova, et al.
Published: (2022-01-01)

Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
by: Milan Melník, et al.
Published: (2023-06-01)